9971
|
|
|
Phospholipase A2 group VI |
CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2, iPLA2beta |
Asthma, Autism, Parkinson disease, Basal cell carcinoma, Skin neoplasms, Bipolar disorder, Breast cancer, Cancer, Cerebellar ataxia, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Color vision deficiency, Colorectal cancer, Congenital neurologic anomalies, Melanoma, Developmental regression, Diabetes mellitus, Diverticular disease, Dystonia, Estrogen-receptor negative breast cancer, Global developmental delay, Hallervorden spatz syndrome, Lung cancer, Melanocytic nevus, Metabolic syndrome, Neurodegeneration with brain iron accumulation, Non-organic psychosis, Osteopetrosis and infantile neuroaxonal dystrophy, Ovarian cancer, Ovarian serous carcinoma, Pelvic organ prolapse, Prostate cancer, Psychotic disorders, Schizophrenia, Spastic ataxia, Squamous cell carcinoma, Diabetes mellitus type 2, Uterine prolapseView all (22 more) |
9972
|
|
|
Phospholipase A2 group VII |
LDL-PLA2, LP-PLA2, PAFAD, PAFAH |
Asthma, Atherosclerosis, Cerebrovascular disorder, Ischemic heart disease, Coronary artery disease, Diabetes mellitus type 2, Hemolytic uremic syndrome, Hypersensitivity, Nephrotic syndrome, Iga nephropathy, Myocardial ischemia, Stroke |
9973
|
|
|
Phospholipase A2 receptor 1 |
CLEC13C, PLA2-R, PLA2G1R, PLA2IR, PLA2R |
|
9974
|
|
|
Phospholipase A2 activating protein |
DOA1, NDMSBA, PLA2P, PLAP |
|
9975
|
|
|
Phospholipase A and acyltransferase 2 |
HRASLS2, PLA1/2-2, PLAAT-2 |
|
9976
|
|
|
Phospholipase A and acyltransferase 3 |
AdPLA, FPLD9, H-REV107, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3, PLA2G16, PLAAT-3 |
|
9977
|
|
|
Phospholipase A and acyltransferase 4 |
HRASLS4, HRSL4, PLA1/2-3, PLAAT-4, RARRES3, RIG1, TIG3 |
|
9978
|
|
|
Placenta enriched 1 |
CT92, OOSP2B, OOSP2L |
|
9979
|
|
|
Placenta associated 8 |
C15, DGIC, PNAS-144, onzin |
|
9980
|
|
|
PLAG1 zinc finger |
PSA, SGPA, SRS4, ZNF912 |
|
